The maximum % inhibition at 20 μg mL−1 inhibitor (MG-Fib+IgG) concentration for the T2DM group was 51.89 ± 4.74 (44.80-62.90); for the ATH group, it was 41.23 ± 4.50 (32.10-49.30); and for the T2DM-ATH group, it was found to be 59.25 ± 6.43 (44.70-73.50). The gene discussed is FBL; the disease is type 2 diabetes mellitus.